

Inactive· since Aug 11, 2026
- 31
- days it ran
- 0
- relaunches
Ad copy
Microneedling is good. Microneedling with ASCE+ exosomes takes skin rejuvenation even further. ✨ A peer-reviewed, randomized split-face clinical study evaluated 28 adults over 12 weeks. Each participant received microneedling on both sides of the face—but only one side was treated with ASCE+ Derma Signal SRLV-S, an adipose stem cell-derived exosome-containing solution. After three treatment sessions, the ASCE+ exosome-treated side showed: ✨ Up to 14.4% reduction in wrinkle-related skin roughness ✨ 11.3% improvement in skin elasticity ✨ 6.5% increase in skin hydration ✨ 9.9% reduction in the melanin index, associated with more even-looking skin tone ✨ Greater overall aesthetic improvement than microneedling alone Skin tissue analysis also showed increased collagen density, elastic fibers and newly synthesized collagen on the exosome-treated side. "Most importantly, no serious adverse events were reported. Temporary redness, swelling or pinpoint bruising related to treatment resolved naturally within one week." Not just temporary glow—clinically measured improvements in wrinkles, firmness, hydration and pigmentation. Discover the science of skin regeneration with ASCE+ exosome technology. Results are based on a 28-participant clinical study combining ASCE+ SRLV-S with professional microneedling. Individual results may vary. Treatment should be performed by a qualified healthcare professional.
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.







